Publicaciones científicas

32 Publicaciones científicas disponibles

  • COVID-19 retinal microangiopathy as an in vivo biomarker of systemic vascular disease?

    30 de julio de 2020 | Revista: Journal of Internal Medicine

    M F Landecho  1   2 , J R Yuste  1   2   3 , E Gándara  4 , P Sunsundegui  1   2 , J Quiroga  1   2   5 , A B Alcaide  1   6 , A García-Layana  4

    (1) From the, Covid19 Department, Clinica Universidad de Navarra, Pamplona, Navarra, Spain.
    (2) Internal Medicine Department, Clinica Universidad de Navarra, Pamplona, Navarra, Spain.
    (3) Microbiology and Infectious Diseases Division, Clinica Universidad de Navarra, Pamplona, Navarra, Spain.
    (4) Ophtalmology Department, Clinica Universidad de Navarra, Pamplona, Navarra, Spain.
    (5) CIBEREHD.
    (6) Pulmonary Medicine Department, Clinica Universidad de Navarra, Pamplona, Navarra, Spain.


  • Safety and tolerability of more than 6 days of tedizolid treatment

    20 de abril de 2020 | Revista: Antimicrobians Agents and Chemotherapy

    Mensa Vendrell M (1), Tasias Pitarch M (2), Salavert Lletí M (2), Calabuig Muñoz E (2), Morata Ruiz L (3), Castells Lao G (4), López Suñé E (4), Mensa Pueyo J (3), Oltra Sempere MR (5), Pedro-Botet Montoya ML (6), Isernia V (6), Reynaga Sosa EA (6), Moreno Nuñez L (7), Pasquau Liaño J (8), Sequera Arquelladas S (8), Yuste Ara JR (9), Soriano Viladomiu A (10).

    (1) Pharmacy Department, Hospital Plató, Barcelona, Spain. 
    (2) Department of Infectious Diseases, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
    (3) Department of Infectious Diseases, Hospital Clinic, University of Barcelona, Barcelona, Spain.
    (4) Pharmacy Department, Hospital Clinic, Barcelona, Spain.
    (5) Department of Infectious Diseases, Hospital Clínico Universitario de València, Valencia, Spain.
    (6) Department of Infectious Diseases, Hospital Germans Trias i Pujol, Barcelona, Spain.
    (7) Department of Infectious Diseases, Hospital Universitario Fundación Alcorcón, Madrid, Spain.
    (8) Department of Infectious Diseases, Hospital Universitario Virgen de las Nieves de Granada, Granada, Spain.
    (9) Department of Infectious Diseases, Clínica Universidad de Navarra, Navarra, Spain.
    (10) Department of Infectious Diseases, Hospital Clinic, University of Barcelona, Barcelona, Spain.


  • Adoptive T-cell therapy with CD45RA-deplected donor in the treatment of cytomegalovirus disease in immunocompromised non-transplant patients

    26 de marzo de 2019 | Revista: Antiviral Therapy

    Yuste JR (1,2), Díaz de Cerio AL (3,4), Rifón J (4), Moreno C (3), Panizo M (1), Inogés S (3,4).

    (1) Division of Infectious Diseases, Clínica Universidad de Navarra, Pamplona, Spain.
    (2) Department of Internal Medicine, Clínica Universidad de Navarra, Pamplona, Spain.
    (3) Immunology and Immuotherapy Department, Clínica Universidad de Navarra, Pamplona, Spain.
    (4) Hematology Service and Cell Therapy Area, Clínica Universidad de Navarra, Pamplona, Spain.


  • Intracavitary and systemic daptomycin for successful treatment of a postpneumonectomy intrathoracic infection

    28 de agosto de 2017 | Revista: Antimicrobial Agents Chemotherapy

    Sangro P (1), Carmona-Torre F (1,2), Mesa M (3), Del Pozo JL (2,4), Yuste JR (5,2). (1) Department of Internal Medicine, Clínica Universidad de Navarra, Pamplona, Spain.
    (2) Division of Infectious Diseases, Clínica Universidad de Navarra, Pamplona, Spain.
    (3) Department of Thoracic Surgery. Clínica Universidad de Navarra, Pamplona, Spain.
    (4) Department of Clinical Microbiology, Clínica Universidad de Navarra, Pamplona, Spain.
    (5) Department of Internal Medicine, Clínica Universidad de Navarra, Pamplona, Spain.